Increasingly sophisticated detection of lymph node metastases the problems of stage migration;Steeds geavanceerder detectie van lymfkliermetastasen: De problemen van stadiummigratie

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 35, 1999, Pages 1766-1761

  Giard, R W M ^a   Coebergh, J W W ^b  

^a St Clara Hospital   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BREAST CARCINOMA; CANCER STAGING; HISTOPATHOLOGY; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PROSTATE CARCINOMA;

DIAGNOSTIC TECHNIQUES AND PROCEDURES; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0033612948     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hölzel D, Klamert A, Schmidt M. Krebs: Häufigkeiten, Befunde und Behandlungsergebnisse. München: Zuckschwerdt Verlag; 1996. p. 297-311.
2. Saphir O, Amromin GD. Obscure axillary lymph node metastasis in carcinoma of the breast. Cancer 1948;i:238-41.
3. Siegel RJ. Surgical pathology of lymph nodes in cancer staging: routine and specialized techniques. Surg Oncol Clin N Am 1996;5: 25-31.
4. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastascs from breast cancers. Lancet 1990;335:1565-8.
5. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88-95.
6. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188-97.
7. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm Fk, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
8. Roukos DH. Extended lymphadenectomy in gastric cancer: when, for whom and why. Ann R Coll Surg Engl 1998;80:16-24.
9. Andersen J, Jensen J. Lymph node identification. Specimen radiography of tissue predominated by fat. Am J Clin Pathol 1977;68: 511-2.
10. Wilkinson EJ, Hause L. Probability in lymph node sectioning. Cancer 1974;33:1269-74.
11. Hartveit F. The routine histological investigation of axillary lymph nodes for metastastatic breast cancer. J Pathol 1984;143:187-91.
12. Doglioni C, Dell'Orto P, Zanetti G, Iuzzolino P, Coggi G, Viale G. Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 1990;416:479-90.
13. Raj GV, Moreno JG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 1998; 82:1419-42.
14. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417-20.
15. Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 1996;78:10-6.
16. Sloane JP. Molecules and micrometastases. Lancet 1995;345:1255-6.
17. Zippelius A, Kufer P, Honold G, Köllerman MW, Oberneder R, Schlimok G, et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in hone marrow. J Clin Oncol 1997;15:2701-8.
18. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998;16:2632-40.
19. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
20. Niemann TH, Yilmaz AG, Marsh jr WL, Lucas JG. A half a node or a whole node: comparison of methods for submitting lymph nodes. Am J Clin Pathol 1998;109:571-6.
21. Cady B. Lymph node metastases. Indicators, but not governors of survival. Arch Surg 1984;119:1067-72.
22. Nasser IA, Lee AKC, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in 'node-negative' breast carcinoma. Hum Pathol 1993;24:950-7.
23. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998;280:1410-5.
24. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, et al. Sentinel-lymph-node biopsy for breast cancer - not yet the standard of care. N Engl J Med 1998;339:990-5.
25. Meijer S, Pijpers R, Borgstein PJ, Bleichrodt RP, Diest PJ van. De schildwachtklierprocedure: standaardingreep bij de chirurgische behandeling van het mammacarcinoom. Ned Tijdschr Geneeskd 1998; 142:2235-7.
26. Dixon M. Sentinel node biopsy in breast cancer. A promising technique, but it should not be introduced without proper trials. BMJ 1998;317:295-6.